|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.820 USD | +1.90% |
|
+8.31% | +15.31% |
| 06-15 | Precigen Wins FDA Orphan Drug Exclusivity for Airway Disease Treatment | MT |
| 06-08 | Precigen, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 09:20 AM |
| Market Cap | 1.72B 1.5B 1.39B 1.3B 2.44B 162B 2.45B 16.46B 6.38B 79.81B 6.45B 6.31B 277B | P/E 2026 * |
-161x | P/E 2027 * | 24.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1.72B 1.5B 1.39B 1.3B 2.44B 162B 2.45B 16.46B 6.38B 79.81B 6.45B 6.31B 277B | EV / Sales 2026 * |
13.8x | EV / Sales 2027 * | 7.5x |
| Free-Float |
86.29% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Precigen, Inc.
| 1 day | +1.90% | ||
| 1 week | +8.31% | ||
| Current month | +11.06% | ||
| 1 month | +12.88% | ||
| 3 months | +46.95% | ||
| 6 months | +11.57% | ||
| Current year | +15.31% |
| 1 week | 4.44 |  | 4.9 |
| 1 month | 3.51 | | 4.9 |
| Current year | 3.04 | | 5.46 |
| 1 year | 1.39 | | 5.46 |
| 3 years | 0.65 | | 5.46 |
| 5 years | 0.65 | | 6.96 |
| 10 years | 0.65 | | 32.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Sabzevari
CEO | Chief Executive Officer | 64 | 2019-12-31 |
Harry Thomasian
DFI | Director of Finance/CFO | 64 | 2021-09-30 |
Amy Lankford
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Randal Kirk
CHM | Chairman | 72 | 2008-01-31 |
Cesar Alvarez
BRD | Director/Board Member | 78 | 2008-01-31 |
Jeffrey Kindler
BRD | Director/Board Member | 70 | 2011-11-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-27 | Sell | Chief Operating Officer | -42,703 | 0.0143% | ||
| 05-27 | Sell | General Counsel | -29,131 | 0.0098% | ||
| 05-27 | Sell | Executive/Senior Manager | -30,272 | 0.0101% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.90% | +8.31% | +232.41% | +287.15% | 1.72B | |
| -1.21% | -3.04% | +44.03% | +143.07% | 980B | |
| -2.48% | -5.18% | +52.47% | +39.15% | 550B | |
| -2.14% | -4.94% | +16.83% | +57.08% | 382B | |
| +0.25% | -3.09% | +23.33% | +16.04% | 316B | |
| +0.61% | -1.69% | +27.35% | +13.73% | 272B | |
| +0.22% | -3.10% | +24.67% | +30.49% | 268B | |
| +4.59% | +1.98% | -38.43% | -46.26% | 199B | |
| -1.19% | -4.95% | +16.68% | +47.69% | 182B | |
| -1.35% | -1.46% | +14.06% | +59.26% | 154B | |
| Average | -0.08% | -2.07% | +41.34% | +64.74% | 330.41B | |
| Weighted average by Cap. | -0.78% | -3.67% | +29.59% | +63.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 124M 108M 100M 94.06M 176M 11.74B 177M 1.19B 462M 5.78B 467M 457M 20.07B | 229M 200M 185M 173M 325M 21.61B 327M 2.19B 850M 10.64B 860M 841M 36.93B |
| Net income | -9.08M -7.92M -7.33M -6.86M -12.87M -857M -12.95M -86.97M -33.71M -422M -34.08M -33.35M -1.46B | 75.14M 65.52M 60.68M 56.8M 107M 7.09B 107M 720M 279M 3.49B 282M 276M 12.12B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 4.820 $ | +1.90% | 4,755,744 |
| 26-06-17 | 4.730 $ | -0.42% | 3,834,276 |
| 26-06-16 | 4.750 $ | -1.04% | 3,576,790 |
| 26-06-15 | 4.800 $ | +7.87% | 6,770,942 |
| 26-06-12 | 4.450 $ | -1.77% | 4,562,399 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PGEN Stock
Select your edition
All financial news and data tailored to specific country editions
